Trial intelligence / Profile preview

Chemoprevention of duodenal adenoma progression in familial adenomatous polyposis

2008-003696-43Phase 3Active

Sponsor
KWF Kankerbestrijding
Start
Nov 2008
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of celecoxib and ursodeoxycholic acid in Colonic Adenomatous Polyposis and Duodenal adenoma (DA), sponsored by KWF Kankerbestrijding. Started Nov 2008; status: active.

02

Drugs

celecoxibursodeoxycholic acid
03

Conditions

Colonic Adenomatous PolyposisDuodenal adenoma (DA)

Beyond the preview

Go deeper on 2008-003696-43.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003696-43.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call